P02-303 - Anxio-Depressifs Troubles and Diabetes Type 2

The objective of our study is to estimate the prevalence of depression, anxiety and alexithymia, of patients presenting a diabetes type 2 and their echo on the disease.MethodOur study, descriptive and forward-looking, was led with diabetics type 2, consulting in the service of endocrinology of HEDI CHAKER Hospital of Sfax.The collection of the information was realized with the help of:-A data sheet containing socio-demographic data and clinical data concerning the diabetes.-Hospital-Anxiety and Depression Scale (HADS).-Toronto Alexithymia Scale of 20 items.ResultsOur sample consisted of 96 diabetics: 67 women and 29 men.The average age was of 56.23 years (ET=10, 85)The prevalence of depression was 32.3%, that of anxiety was 56. 3%.The alexithymia was estimated at 46.9%.The depression was correlated to the presence of cardiac co-morbidity (p=0,012).High prevalence of depression was found in diabetic's suffering from neurological (0.002) and renal (p=0.007) complications.The depression was the source of a less regular follow-up.The association depression-alexithymia was correlated at a less good balance of the diabetes (p=0.038).The anxiety does not seem to interfere with the clinical characteristics of the type 2 diabetes.Discussion and conclusionDiabetics suffering from depression have more co-morbidity and complications. This risk was increased by the association of alexithymia. So, a screening of the psychiatric symptoms is necessary to improve the quality of life and the evolution of the disease.